CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-03 | Griffin Deborah A Chief Accounting Officer | Option exercise | +1,166 | 4,107 | ||
| 2019-03-03 | Griffin Deborah A Chief Accounting Officer | Option exercise · Restricted Share Units | −1,166 | 2,332 | ||
| 2019-03-03 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise | +1,399 | 8,663.7 | ||
| 2019-03-03 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise · Restricted Share Units | −1,399 | 2,799 | ||
| 2019-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise | +2,098 | 2,098 | ||
| 2019-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −2,098 | 4,199 | ||
| 2019-03-02 | Griffin Deborah A Chief Accounting Officer | Option exercise | +2,941 | 2,941 | ||
| 2019-03-02 | Griffin Deborah A Chief Accounting Officer | Option exercise · Restricted Share Units | −2,941 | 8,823 | ||
| 2019-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +3,926 | 6,900.39 | ||
| 2019-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −3,926 | $17.74 | $70K | 2,974.39 |
| 2019-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −3,926 | 7,852 | ||
| 2019-02-14 | Sabag Mark EVP, Global Human Resources | Option exercise | +5,710 | 56,607.54 | ||
| 2019-02-14 | Sabag Mark EVP, Global Human Resources | Option exercise · Restricted Share Units | −5,710 | 11,422 | ||
| 2019-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +5,353 | 17,178.51 | ||
| 2019-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −1,841 | $17.67 | $33K | 15,337.51 |
| 2019-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −5,353 | 10,708 | ||
| 2019-02-14 | de Notaristefani Carlo Executive VP Global Operations | Option exercise | +9,280 | 21,400.73 | ||
| 2019-02-14 | de Notaristefani Carlo Executive VP Global Operations | Sale | −3,192 | $17.67 | $56K | 18,208.73 |
| 2019-02-14 | de Notaristefani Carlo Executive VP Global Operations | Option exercise · Restricted Share Units | −9,280 | 18,560 | ||
| 2019-02-14 | Codner Iris Beck EVP Global Brand&Communication | Option exercise | +3,212 | 17,996.04 |
Page 68 of 76 · 1,517 trades